Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice

Nature Neuroscience

Volumn 2, Issue 3, 1999, Pages 271-276

  Chapman, Paul F ^a   White, Gail L ^a   Jones, Matthew W ^b   Cooper Blacketer, Deirdre ^c   Marshall, Vanessa J ^a   Irizarry, Michael ^d   Younkin, Linda ^e   Good, Mark A ^a   Bliss, T V P ^b   Hyman, Bradley T ^d   Younkin, Steven G ^e   Hsiao, Karen K ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DENTATE GYRUS; GENE MUTATION; GENE OVEREXPRESSION; HIPPOCAMPUS; LEARNING DISORDER; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; TRANSGENIC MOUSE; WORKING MEMORY;

AGING; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DENTATE GYRUS; HIPPOCAMPUS; HUMANS; LEARNING; LONG-TERM POTENTIATION; MEMORY; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; SPACE PERCEPTION; SYNAPSES;

EID: 0033360356     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/6374     Document Type: Article

References (32)

1. Citron, M. et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672-674 (1992).
2. Cai, X., Golde, T. E. & Younkin, S. G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516 (1993).
3. Suzuki, N. et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1335-1340 (1994).
4. Borchelt, D. R. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ration in vitro and in vivo. Neuron 17, 1005-1013 (1996).
5. Duff, K. et al. Increased amyloid-beta 42(43) in brains of mice expressing presenilin 1. Nature 383, 710-713 (1996).
6. Goate, A. M. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991).
7. Mullan, M. et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1, 345-347 (1992).
8. Chartier-Harlin, M. C. et al. Early-onset Alzheimer's disease caused by mutation at codon 717 of the β-amyloid precursor protein gene. Nature 353, 844-846 (1991).
9. Murrell, J., Farlow, M., Getti, B. & Benson, M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99 (1991).
10. Hendriks, L. et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat. Genet. 1, 218-221 (1992).
11. Eckman, C. B. et al. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A-beta 42(43). Hum. Mol. Genet. 6, 2087-2089 (1997).
12. Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159 (1997).
13. Hsiao, K. K. et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
14. SW transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CAI. J. Neuropathol. Exp. Neurol. 56, 965-973 (1997).
15. SW transgenic mice. Am. J. Pathol. 152, 307-317 (1998).
16. Bliss, T. V. P. & Collingridge, G. L. A synaptic model of memory - long-term potentiation in the hippocampus. Nature 361, 31-39 (1993).
17. Errington, M. L., Bliss, T. V. P., Morris, R. J., Laroche, S. & Davis, S. Long-term potentiation in awake mutant mice. Nature 387, 666-667 (1997).
18. Zucker, R. S. Short-term synaptic plasticity. Annu. Rev. Neurosci. 12, 13-31 (1989).
19. Hyman, B. T., Van Hoesen, G. W., Kromer, L. J. & Damasio, A. R. Perforant pathway change and the memory impairment of Alzheimer's disease. Ann. Neurol. 20, 473-482 (1986).
20. Finch, C. E. Neuron atrophy during aging: programmed or sporadic? Trends Neurosci. 16, 104-110 (1993).
21. Schauwecker, P. E. & Steward, O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl. Acad. Sci. USA 94, 4103-4108 (1997).
22. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448-6453 (1998).
23. Nalbantoglu, J. et al. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500-505 (1997).
24. Südhof, T. C. The synaptic vesicle cycle: a cascade of protein-protein interaction. Nature 375, 645-653 (1995).
25. Luthi, A., Laurent, J. P., Figurov, A., Muller, D. & Schachner, M. Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM. Nature 372, 777-779 (1994).
26. Dragunow, M. A role for immediate-early transcription factors in learning and memory. Behav. Genet. 26, 293-299 (1996).
27. Ikezu, T. et al. Negative transactivation of cAMP response element by familial Alzheimer's mutants of APP. EMBO J. 15, 2468-2475 (1996).
28. Castillo, P. E. et al. Rab3A is essential for mossy fibre long-term potentiation in the hippocampus. Nature 388, 590-593 (1997).
29. Kang, H., Welcher, A. A., Shelton, D. & Schuman, E. M. Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron 19, 653-664 (1997).
30. Giese, K. P., Federov, N. B., Filipkowski, R. K. & Silva, A. J. Autophosphorylation at threonine 286 of the α calcium-calmodulin-kinase II in LTP and learning. Science 279, 870 (1998).
31. Klann, E., Chen, S. J. & Sweatt, J. D. Persistent protein kinase activation in the maintenance phase of long-term potentiation. J. Biol. Chem. 266, 24253-24256 (1991).
32. Winder, D. G., Mansuy, I. M., Osman, M., Moallem, T. M. & Kandel, E. R. Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 92, 25-37 (1998).